Urinary nerve growth factor in women with overactive bladder syndrome

BJU International

Volumn 107, Issue 5, 2011, Pages 799-803

  Liu, Hsin Tzu ^a   Chen, Chia Yen ^a   Kuo, Hann Chorng ^a  

^a TZU CHI UNIVERSITY   (Taiwan)

Author keywords

detrusor overactivity; menopause; nerve growth factor; obesity; overactive bladder

Indexed keywords

CREATININE; NERVE GROWTH FACTOR;

ADULT; AGE; AGING; ARTICLE; BODY MASS; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE CLASSIFICATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; OVERACTIVE BLADDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL;

AGED; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; NERVE GROWTH FACTOR; OBESITY; URINARY BLADDER, OVERACTIVE; URINARY INCONTINENCE, URGE; URODYNAMICS;

EID: 79952262866     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09585.x     Document Type: Article

References (28)

1. Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynecologicval Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn 2010; 29: 4-20
2. Zhang W, Song Y, He X, Huang H, Xu B, Song J,. Prevalence and risk factors of overactive bladder syndrome in Fuzhou Chinese women. Neurourol Urodyn 2008; 25: 717-21
3. Lee YS, Lee KS, Jung JH, et al. Prevalence of overactive bladder, urinary incontinence, and lower urinary tract symptoms: results of Korean EPIC study. World J Urol 2009; Nov 8 [Epub ahead of print]
4. Milsom I,. Lower urinary tract symptoms in women. Curr Opin Urol 2009; 19: 337-41
5. Coyne KS, Margolis MK, Jumadilova Z, Bavendam T, Mueller E, Rogers R,. Overactive bladder and women's sexual health: what is the impact? J Sex Med 2007; 4: 656-66 (Pubitemid 46779301)
6. Parazzini F, Chiaffarino F, Lavezzari M, Giambanco V, VIVA Study Group. Risk factors for stress, urge or mixed urinary incontinence in Italy. BJOG 2003; 110: 927-33 (Pubitemid 37204949)
7. Cheung WW, Khan NH, Choi KK, Bluth MH, Vincent MT,. Prevalence, evaluation and management of overactive bladder in primary care. BMC Fam Pract 2009; 10: 8
8. Teleman PM, Lidfeldt J, Nerbrand C, Samsioe G, Mattiasson A, WHILA Study Group. Overactive bladder: prevalence, risk factors and relation to stress incontinence in middle-aged women. BJOG 2004; 111: 600-4 (Pubitemid 38746245)
9. Bunyavejchevin S,. Risk factors of female urinary incontinence and overactive bladder in Thai postmenopausal women. J Med Assoc Thai 2005; 88 (Suppl. 4): S119-23
10. Lin TL, Ng SC, Chen YC, Hu SW, Chen GD,. What affects the occurrence of nocturia more: menopause or age? Maturitas 2005; 50: 71-7
11. Haylen BT, Chetty N, Logan V, et al. Is sensory urgency part of the same spectrum of bladder dysfunction as detrusor overactivity? Int Urogynecol J Pelvic Floor Dysfunct 2007; 18: 123-8
12. Lowe EM, Anand P, Terenghi G, Williams-Chestnut RE, Sinicropi DV, Osborne JL,. Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis. Br J Urol 1997; 79: 572-7 (Pubitemid 28321098)
13. Steers WD, Kolbeck S, Creedon D, Tuttle JB,. Nerve growth factor in the urinary bladder of the adult regulates neuronal form and function. J Clin Invest 1991; 88: 1709-15
14. Dupont MC, Spitsberegen JM, Kim KB, Tuttle JB, Steers WD,. Histological and neurotrophic changes triggered by varying models of bladder inflammation. J Urol 2000; 166: 1111-8 (Pubitemid 32751054)
15. Kim JC, Park EY,. Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder. J Urol 2006; 175: 1773-6
16. Liu HT, Kuo HC,. Urinary nerve growth factor level could be a potential biomarker for diagnosis of overactive bladder. J Urol 2008; 179: 2270-4
17. Liu HT, Chancellor MB, Kuo HC,. Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection. Eur Urol 2009; 56: 700-6
18. Saini R, Gonzalez RR, Te AE,. Chronic pelvic pain syndrome and the overactive bladder: the inflammatory link. Curr Urol Rep 2008; 9: 314-9
19. Apostolidis A, Jacques TS, Freeman A, et al. Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity. Eur Urol 2008; 53: 1245-53
20. Tyagi P, Barclay D, Zamora R, et al. Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study. Int Urol Nephrol 2009; Sep 26 [Epub ahead of print]
21. Tyagi P, Vodovotz Y, Kuo HC, Yoshimura N, Chancellor MB,. Urine cytokines exhibit the bladder inflammation in the overactive bladder; pilot study. Urology 2009 [Epub ahead of print]
22. Hashim H, Abrams P,. Is the bladder a reliable witness for predicting detrusor overactivity? J Urol 2006; 175: 191-5
23. Hyman MJ, Groutz A, Blaivas JG,. Detrusor instability in men: correlation of lower urinary tract symptoms with urodynamic findings. J Urol 2001; 166: 550-3 (Pubitemid 32652245)
24. Chen GD, Lin TL, Hu SW, Chen YC, Lin LY,. Prevalence and correlation of urinary incontinence and overactive bladder in Taiwanese women. Neurourol Urodyn 2003; 22: 109-17
25. Dallosso HM, McGrother CW, Matthews RJ, Dobaldson MM, Leicestershire MRC Incontinence Study Group. The association of diet and other lifestyle factors with overactive bladder and stress incontinence: a longitudinal study in women. BJU Int 2003; 92: 69-77 (Pubitemid 36843031)
26. Chancellor MB, Oefelein MG, Vasavada S,. Obesity is associated with a more severe overactive bladder disease state that is effectively treated with once-daily administration of trospium chloride extnded release. Neurourol Urodyn 2010; 29: 551-4
27. McVary K,. Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology. BJU Int 2006; 97 (Suppl. 2): 23-8
28. Wennberg AL, Molander U, Fall M, Edlund C, Peeker R, Milsom I,. A longitudinal population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in women. Eur Urol 2009; 55: 783-91